Goldman Sachs’s Artiva Biotherapeutics, Inc. Common Stock ARTV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$178K	Buy	118,003 +76,051	+181%	+$115K	﹤0.01%	4758
2025 Q1	$126K	Buy	41,952 +3,882	+10%	+$11.6K	﹤0.01%	4777
2024 Q4	$384K	Buy	38,070 +8,523	+29%	+$85.9K	﹤0.01%	4424
2024 Q3	$457K	Buy	+29,547	New	+$457K	﹤0.01%	4155